Assessment of serological markers associated with rheumatoid arthritis. Diagnostic autoantibodies and conventional disease activity markers

Clinical and Applied Immunology Reviews

Volumn 4, Issue 2, 2003, Pages 109-123

  Marcelletti, John F ^a   Nakamura, Robert M ^a,b  

^a Prometheus Laboratories   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Diagnostic autoantibodies; Disease activity markers; Rheumatoid arthritis

Indexed keywords

AMYLOID A PROTEIN; ANTINUCLEAR ANTIBODY; ANTIPERINUCLEAR FACTOR; AUTOANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CITRULLINE; EPITOPE; FILAGGRIN; GLUCOSE 6 PHOSPHATE ISOMERASE; ISOPROTEIN; KERATIN ANTIBODY; PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; PATIENT MONITORING; PREDICTION; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

EID: 0041387307     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(03)00048-5     Document Type: Review

References (74)

1. Arnett F.C. Edworthy S.M. Bloch D.A. McShane D.J. Fries J.F. Cooper N.S. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315-324
2. Nakamura R.M. Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis J Clin Lab Anal 14 2000 305-313
3. Pinals R.S. Polyarthritis and fever N Engl J Med 330 1994 769-774
4. Saraux A. Berthelot J.M. Chales G. Le Henaff C. Thorel J.B. Hoang S. et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later Arthritis Rheum 44 2001 2485-2491
5. Kim J.M. Weisman M.H. When does rheumatoid arthritis begin and why do we need to know? Arthritis Rheum 32 2000 473-484
6. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines Guidelines for the management of rheumatoid arthritis Arthritis Rheum 46 2002 328-346
7. Posnett D.N. Edinger J. When do microbes stimulate rheumatoid factor? J Exp Med 185 1997 1721-1723
8. Soltys A.J. Axford J.S. Sutton B.J. Rheumatoid factor: where are we now? Ann Rheum Dis 56 1997 281-286
9. Moore T.L. Dorner R.W. Rheumatoid factors Clin Biochem 26 1993 75-84
10. Hamako J. Ozeki Y. Matsui T. Yoshinobu Y. Inoue T. Yukitake J. et al. Binding of human IgM from a rheumatoid factor to IgG of 12 animal species Comp Biochem Physiol 112B 1995 683-688
11. Ulvestad E. Wilfred L.L. Kristoffersen E.K. Measurement of IgM rheumatoid factor by ELISA Scand J Rheumatol 30 2001 366
12. Bas S. Perneger T.V. Kunzle E. Vischer T.L. Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factor Ann Rheum Dis 61 2002 505-510
13. Houssien D.A. Jonsson T. Daview E. Scott D.L. Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis. Comparative effects of different antigens Scand J Rheumatol 27 1998 46-53
14. Bukhari M. Lunt M. Harrison B.J. Scott D.G.I. Symmons D.P.M. Silman A.J. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis. Results from the Norfolk Arthritis Register Study, a large inception cohort Arthritis Rheum 46 2002 906-912
15. Combe B. Dougados M. Goupille P. Cantagrel A. Eliaou J.F. Sibilia J. et al. Prognostic factors for radiographic damage in early rheumatoid arthritis a multiparameter prospective study Arthritis Rheum 44 2001 1736-1743
16. Scott D.L. Prognostic factors in early rheumatoid arthritis Rheumatology 39 suppl. 1 2000 24-29
17. Eggelmeijer F. Otten H.G. de Rooy H.H. Daha M.R. Breedveld F.C. Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis Rheumatol Int 10 1990 43-46
18. Swedler W. Wallman J. Froelich C.J. Teodorescu M. Routine measurement of IgM, IgG, and IgA Rheumatoid Factors: High sensitivity, specificity, and predictive value for rheumatoid Arthritis J Rheumatol 24 1997 1037-1044
19. Jonsson T. Steinsson K. Jonsson H. Geirsson A.J. Thorsteinsson J. Valdimarsson H. Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis Rheumatol Int 18 1998 119-122
20. van Leeuwen M.A. Westra J. van Riel P.L.C.M. Limburb P.C. van Rijswijk M.H. IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 24 1995 146-153
21. Valdimarrsson H. Jonsson T. Predictive value of rheumatoid factor isotypes for radiological progression in patients with rheumatoid arthritis Scand J Rheumatol 25 1996 189-190
22. Pai S. Pai L. Birkenfeldt R. Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis Scand J Rheumatol 27 1998 252-256
23. Jorgensen C. Legouffe M.C. Bologna C. Brochier J. Sany J. IgA isotype rheumatoid factor in rheumatoid arthritis: clinical implications Clin Exp Rheumatol 14 1996 301-304
24. Teitsson I. Withrington R.H. Seifert M.H. Valdimarsson H. Prospective study of early rheumatoid arthritis: I. Prognostic value of IgA rheumatoid factor Ann Rheum Dis 43 1984 673-678
25. Van Zeben D. Hazes J.M.W. Zwinderman A.H. Cats A. van der Voort E.A.M. Breedveld F.C. Clinical significance of rheumatoid factor isotypes in early rheumatoid arthritis: results of a follow-up study Ann Rheum Dis 51 1992 1029-1035
26. van Leeuwen M.A. Reply Scand J Rheumatol 25 1996 190
27. van Boekel M.A.M. Vossenaar E.R. van den Hoogen F.H.J. van Venrooij W.J. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value Arthritis Research 4 2002 87-93
28. Schellekens G.A. de Jong B.A. van den Hoogen F.H. van de Putte L.B. van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J Clin Invest 101 1998 273-281
29. Union A. Meheus L. Humbel R.L. Conrad K. Steiner G. Moereels H. et al. Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay Arthritis Rheum 46 2002 1185-1195
30. Hueber W. Hassfeld W. Smolen J.S. Steiner G. Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis Rheumatology 38 1999 155-159
31. Menard H.A. Lapointe E. Rochdi M.D. Zhou Z.J. Insights into rheumatoid arthritis derived from the Sa immune system Arthritis Research 2 2000 429-432
32. Schellekens G.A. Visser H. de Jong B.A. van den Hoogen F.H. Hazes J.M. Breedveld F.C. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum 43 2000 155-163
33. Bizzaro N. Mazzanti G. Tonutti E. Villalta D. Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis Clin Chem 47 2001 1089-1093
34. Goldbach-Mansky R. Lee J. McCoy A. Hoxworth J. Yarboro C. Smolen J.S. et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset Arthritis Research 2 2000 236-243
35. Sauaux A. Berthelot J.M. Chales G. Le Henaff C. Mary J.Y. Thorel J.B. et al. Value of laboratory tests in early prediction of rheumatoid arthritis Arthritis Rheum 47 2002 155-165
36. Kroot E.J. de Jong B.A. van Leeuwen M.A. Swinkels H. van den Hoogen F.H. van't Hof M. et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis Rheum 43 2000 1831-1835
37. Visser H. le Cessie S. Vos K. Breedveld F.C. Hazes J.M. How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis Arthritis Rheum 46 2002 357-365
38. Kavanaugh A. Tomar R. Reville J. Solomon D.H. Homburger H.A. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens Arch Pathol Lab Med 124 2000 71-81
39. Caspi D. Elkayam O. Eisinger M. Vardinon N. Yaron M. Burke M. Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease Rheumatol Int 20 2001 43-47
40. Meyer O. Tauxe F. Fabregas D. Gabay C. Goycochea M. Haim T. et al. Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies Clin Exp Rheumatol 11 1993 473-478
41. Meyer O. Combe B. Elias A. Benali K. Clot J. Sany J. et al. Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation of two subsets of patients according to severity of radiographic damage Ann Rheum Dis 56 1997 682-685
42. Mediwake R. Isenberg D.A. Schellekens G.A. van Venrooij W.J. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythrmatosus and rheumatoid arthritis Ann Rheum Dis 60 2001 67-68
43. Schaller M. Burton D.R. Ditzel H.J. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease Nat Immunol 2 2001 746-753
44. Blass S. Union A. Raymackers J. Schumann F. Ungethum U. Muller-Steinbach S. et al. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis Arthritis Rheum 44 2001 761-771
45. Schubert D. Schmidt M. Zaiss D. Jungblut P.R. Kamradt T. Autoantibodies to GPI and creatine kinase in RA Nat Immunol 3 2002 411
46. Kassahn D. Kolb C. Solomon S. Bochtler P. Illges. Few human autoimmune sera detect GPI Nat Immunol 3 2002 411-412
47. Schaller M. Benoit V.M. Ditzel H.J. Response Nat Immunol 3 2002 412-413
48. Blab S. Meier C. Vohr H.W. Schwochau M. Specker C. Burmester G.R. The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies Ann Rheum Dis 57 1998 220-225
49. Corrigall V.M. Bodman-Smith M.D. Fife M.S. Canas B. Meyers L.K. Wooley P.H. et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis J Immunol 166 2001 1492-1498
50. Del Puente A. Knowler W.C. Pettitt D.J. Bennett P.H. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study Arthritis Rheum 31 1988 1239-1244
51. Jonsson T. Thorsteinsson J. Kolbeinsson A. Jonasdottir E. Sigfusson N. Valdimarsson H. Population study of the importance of rheumatoid factor isotypes in adults Ann Rheum Dis 51 1992 863-868
52. Jonsson T. Thorsteinsson J. Valdimarsson H. Elevation of only one rheumatoid factor isotype is not associated with increased prevalence of rheumatoid arthritis-a population based study Scand J Rheumatol 29 2000 190-191
53. Aho K. Palosuo T. Heliovaara M. Knekt P. Alha P. von Essen R. Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion J Rheumatol 27 2000 2743-2746
54. Masi A.T. Aldat J.C. Do antifilaggrin antibodies within the "normal" range predict rheumatoid arthritis? J Rheumatol 28 2001 1736-1737
55. Aho K. Palosuo T. Heliovaara M. Knekt P. Alha P. von Essen R. Reply J Rheumatol 28 2001 1738-1739
56. Aho K. Palosuo T. Knekt P. Alha P. Aromaa A. Heliovaara M. Serum C-reactive protein does not predict rheumatoid arthritis J Rheumatol 27 2000 1136-1138
57. Huizinga T.W.J. Machold K.P. Breedveld F.C. Lipsky P.E. Smolen J.S. Criteria for early rheumatoid arthritis. From Bayes' law revisitied to new thoughts on pathogenesis Arthritis Rheum 46 2002 1155-1159
58. Scott D.L. The diagnosis and prognosis of early arthritis: Rationale for new prognostic criteria Arthritis Rheum 46 2002 286-290
59. Meyer O. Labarre C. Dougados M. Goupille Ph. Cantagrel A. Dubois A. et al. Anticirtullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Arthritis Rheum 62 2003 120-126
60. Scott D.L. Prognostic factors in early rheumatoid arthritis Rheumatology 39 suppl. 1 2000 24-29
61. Jansen L.M. van der Horst-Bruinsma I.E. van Schaardenburg D. Bezemer P.D. Dijkmans B.A. Predictors of radiographic joint damage in patients with early rheumatoid arthritis Ann Rheum Dis 60 2001 924-927
62. Plant M.J. Williams A.L. O'Sullivan M.M. Lewis P.A. Coles E.C. Jessop J.D. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis Arthritis Rheum 43 2000 1473-1477
63. Pinals R.S. Baum J. Bland J. Fosdick W.M. Kaplan S.B. Masi A.T. et al. Preliminary criteria for clinical remission in rheumatoid arthritis Bull Rheum Dis 32 1982 7-10
64. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis J Rheumatol 24 1997 1477-1485
65. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness Clin Chem Lab Med 37 1999 381-388
66. Vallon R. Freuler F. Desta-Tsedu N. Robeva A. Dawson J. Wenner P. et al. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases J Immunol 166 2001 2801-2807
67. Cunnane G. Grehan S. Geoghegan S. McCormack C. Shields D. Whitehead A.S. et al. Serum amyloid A in the assessment of early inflammatory arthritis J Rheumatol 27 2000 58-63
68. Chambers R.E. MacFarlane D.G. Whicher J.T. Dieppe P.A. Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity Ann Rheum Dis 42 1983 665-667
69. Grindulis K.A. Scott D.L. Robinson M.W. Bacon P.A. McConkey B. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs Br J Rheumatol 24 1985 158-163
70. Whicher J.T. Chambers R.E. Higginson J. Nashef L. Higgins P.G. Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza J Clin Pathol 38 1985 312-316
71. Nakayama T. Sonoda S. Urano T. Yamada T. Okada M. Monitoring both serum amyloid A and C-reactive protein as inflammatory markers in infectious diseases Clin Chem 39 1993 293-297
72. Whicher J. Bienvenu J. Monneret G. Procalcitonin as an acute phase marker Ann Clin Biochem 38 2001 483-493
73. Eberhard O.K. Haubitz M. Brunkhorst F.M. Kliem V. Koch K.M. Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection Arthritis Rheum 40 1997 1250-1256
74. Schwenger V. Sis J. Breitbart A. Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin Infection 26 1998 274-276